FAVIPIRAVIR
COVID-19 Treatment Effects: Infant’s Brown Eyes Turn Blue Overnight After Coronavirus Treatment in Thailand, Says Report
New COVID-19 Guidelines: Antibiotics Shouldn't Be Used in COVID-19 Unless Suspicion of Bacterial Infection, Says Central Govt
IT Department Detects Rs 550-Crore Hidden Income After Raids on Hyderabad-Based Hetero Pharma Group; Rs 142-Crore Cash Seized (See Pic)
India Gets 12 Lakh Favipiravir, 6.9 Lakh Remdesivir Vials in Foreign Aid, Immediate Allocation to the Recipient States, UTs and Institutions: Union Health Ministry
COVID-19 Drug Update: Favipiravir Provides Multiple Benefits in Coronavirus Treatment, Says Glenmark Pharmaceuticals
COVID-19 Medication Update: Russia Approves First Prescription Drug 'Coronavir' For Outpatients With Mild to Moderate Infections
Cipla Gets DCGI Nod to Sell Favipiravir Under Brand 'Ciplenza' to Treat Mild And Moderate COVID-19 Patients
Jenburkt Pharma Launches COVID-19 Drug Favipiravir Under Brand Name 'Favivent' at Rs 39 Per Tablet
Cipla Gets Regulatory Nod from DCGI for Launch of Ciplenza to Treat Mild to Moderate COVID-19
Glenmark Announces Top-line Results from Phase 3 Clinical Trial of Favipiravir in Patients with Mild to Moderate COVID-19
Google Trends